Evaluation of [123I] AV51 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00556660
Recruitment Status : Completed
First Posted : November 12, 2007
Last Update Posted : July 24, 2008
Information provided by:
Institute for Neurodegenerative Disorders

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2008
  Study Completion Date : July 2008